ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

IOM Committee Will Probe Duke Scandal Together With Other “Omics” Case Studies

January 7, 2011

NIH Investigating Cohn Records Leak

August 15, 1986

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006

IOM Report Urges Providers To Address Psychological Needs Of Cancer Patients.

November 23, 2007

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996